EasySLR
  • Features
  • Pricing
  • Events
ft.svg
EasySLR will be exhibiting at Booth 543 at ISPOR US 2026 in Philadelphia, 17-20 May. Read more →

Fly Through Reviews

Built on advanced Large Language Model (LLM) research, deep domain expertise, and a focus on superior user experience, EasySLR simplifies your systematic review process.

No credit card required
Learn more →

Our Customers and Partners

EasySLR is trusted by leading research organizations, universities, and healthcare consulting firms worldwide:

  • Skyward Analytics
  • Connect HEOR
  • Olson Strategies
  • Niper Mohali
  • Lumanity
  • University of Sydney
  • ASC Academics
  • KGMU
  • University of York
  • Banaras Hindu University
  • Amiculum
  • nate
Skyward Analytics
Connect HEOR
Olson Strategies
Niper Mohali
Lumanity
University of Sydney
ASC Academics
KGMU
University of York
Banaras Hindu University
Amiculum
nate
Skyward Analytics
Connect HEOR
Olson Strategies
Niper Mohali
Lumanity
University of Sydney
ASC Academics
KGMU
University of York
Banaras Hindu University
Amiculum
nate

Trusted by leading organizations

Join thousands of researchers and organizations worldwide

Get started with EasySLR

With EasySLR, you can automate the most time-consuming parts of the process and focus on what you do best. We’ll handle the rest.

1

Title Abstract Screening Made Easy

Review duplicates and screen studies efficiently with AI suggestions

Title & Abstract Screening
Study 142 of 1,247
Screening
#142
Title & Abstract
PubMed · PMID 38291045

Comparative Effectiveness of GLP-1 Receptor Agonists vs DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis

Martinez R, Chen L, Okafor K · Diabetes Care (2024)


Abstract

Background: This systematic review compared the clinical effectiveness of GLP-1 receptor agonists with DPP-4 inhibitors in adults with type 2 diabetes mellitus.

Methods: Thirty-four randomised controlled trials (n=28,042) were included. Eligible studies enrolled adults with type 2 diabetes receiving GLP-1 agonists or DPP-4 inhibitors for ≥12 weeks.

Results: GLP-1 agonists demonstrated superior HbA1c reduction (−0.4%, 95% CI −0.5 to −0.3) and significant weight loss compared with DPP-4 inhibitors.

AI SuggestionAI
Include
High confidence

Rationale

Study compares two pharmacological interventions for T2D management with clinical outcomes. Meets population, intervention, and outcome criteria per protocol.

PICOS Extraction

P

Adults with Type 2 Diabetes

I

GLP-1 receptor agonists

C

DPP-4 inhibitors

O

HbA1c, cardiovascular events

S

Randomized controlled trial

2

Full-Text Screening with AI-Enabled PICOS

Streamline your full-text screening process using AI-powered PICOS extraction

Full-Text Screening
Study 87 of 312
Screening
martinez_chen_2024.pdf
5 / 18
100%

Methods

Study Design: This multi-centre randomized controlled trial was conducted across 24 clinical sites in North America and Europe between January 2021 and December 2023.

Participants: We enrolled 1,842 adults aged 30–75 with confirmed type 2 diabetes and inadequate glycemic control (HbA1c 7.5–11.0%) on metformin monotherapy. Key exclusion criteria included renal impairment (eGFR <30), prior GLP-1RA use, and active cardiovascular disease.

Intervention: Participants were randomized 1:1 to semaglutide 1.0 mg weekly or standard of care for 52 weeks. The primary endpoint was change in HbA1c from baseline at week 52.

AI SuggestionAI
Include
High confidence

Rationale

RCT comparing GLP-1RA vs standard of care in T2D population with HbA1c and cardiovascular endpoints. Meets all eligibility criteria per protocol.

PICOS Extraction

P

Adults with Type 2 Diabetes

I

GLP-1 receptor agonists

C

Standard of care

O

HbA1c, weight, cardiovascular events

S

Randomized controlled trial

3

Automated Data Extraction

Automatically extract key data from studies and link it to highlighted sources for easy verification with our AI-powered tool.

Data Extraction
Processing
johnson_et_al_2024.pdf
3 / 12
100%

Effects of Metformin on Glycemic Control in Adults with Type 2 Diabetes: A Multi-Centre Study

Johnson A, Smith B, Patel C, Williams D

Journal of Clinical Endocrinology & Metabolism, Vol 109 (3), 2024


Abstract

Background: This randomized controlled trial1 evaluated the efficacy of metformin monotherapy in newly diagnosed patients with type 2 diabetes across 12 clinical sites in North America and Europe.

Methods: A total of 245 adults aged 18–65 with confirmed type 2 diabetes2 were enrolled and randomized 1:1 to metformin 1 000 mg daily or matched placebo for 12 weeks. The primary endpoint was change in HbA1c from baseline.

Results: The primary endpoint of HbA1c reduction at 12 weeks3 showed significant improvement in the treatment group (−1.2% vs −0.3%, p<0.001). Secondary endpoints including fasting glucose and body weight also favoured metformin.

Extracted FieldsAI

Study Design

Randomized Controlled Trial

Sources:1

Sample Size

245 participants

Sources:2

Population

Adults 18–65, Type 2 Diabetes

Sources:12

Primary Outcome

HbA1c reduction at 12 wk

Sources:3

Empowering Researchers to Deliver Excellence

Conduct systematic reviews with our AI-powered platform, designed to help you achieve your research goals.

Customizable Workflows

Create custom extraction forms, define protocols, leverage AI and set up workflows that align precisely with your project requirements.

AI-Enhanced Review Expert

Enhance your systematic review with our AI assistant. Functioning as both a proactive Copilot during the screening and data extraction stages, and as an Independent Reviewer alongside human experts.

Collaborative Platform

Collaborate seamlessly with your team on a centralized platform. Assign roles, track progress, and communicate effectively.

Automated Data Extraction

Efficiently and precisely extract key information from studies, automatically linked to highlighted sources for easy verification.

Full-Text Retrieval

Access the full text of studies instantly with just a single click.

Transparent Conflict Resolution

Resolve disagreements among reviewers with ease. Manage consensus and maintain the integrity of your systematic review.

Comprehensive Analytics

Gain valuable insights into your project's progress and performance with real-time analytics dashboard.

SOC2 and ISO27001 Compliant

Rest assured that your data is secure and protected. EasySLR adheres to the highest standards of data privacy and security.

See all features →

Pricing that meets your business needs

MonthlyYearly
2 months free
Currency:
We offer flexible pricing plans suited to your business needs. For details on long-term subscription options, .

Free Trial

$0

Get started for free and see how we can help your business.

  • No Credit Card required
  • Up to 1 project
  • Up to 10 users
  • All Non-AI Features Included
  • Expiry 1 month
  • AI Credits to be purchased separately

Professional Plan

$200
/ seat / month

Everything necessary to get started.

  • Up to 1,000 projects
  • Up to 100 users
  • Email support
  • Chat support
  • All Non-AI Features Included
  • AI Credits to be purchased separately

Enterprise

Custom

A plan personalized as per your needs.

  • Dynamic pricing
  • Priority email support
  • Priority chat support
  • All features included
  • Custom AI Credits

*For all plans, to purchase AI credits seperately, please contact our sales team.

View pricing details →

Got Questions?

We've Got Answers!

Can't find the answer you're looking for? Reach out to our customer support team.

You can connect with our support team or inquire about sales by submitting a query through this link : https://support.easyslr.com/portal/en/newticket

You can also reach out to us by email at : support@easyslr.com

flow.png
flow.pngflow.pngflow.png

Claim your
free project now

No credit card required

EasySLR
soc.pngiso.pnggdpr.png
LinkedInXInstagramYouTube

Product

  • Features
  • Pricing
  • Systematic Review Software
  • Tools Free
  • Knowledge Base
  • Changelog

Company

  • About Us
  • Events
  • Research
  • Methods
  • Blog
  • Book a Demo

Legal

  • Privacy Policy
  • Terms of Service
  • Refund Policy
  • Trust Center

Address

  • Minarch Tower,
    Sector 44,
    Gurugram, HR
    India 122003

Request an AI summary of EasySLR

ChatGPTClaudeGeminiGrokPerplexity

© 2026 EasySLR All rights reserved.